Bellevue Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.28K | Hold |
19
| – | – | ﹤0.01% | 393 |
|
|
2025
Q1 | $2.96K | Buy |
19
+4
| +27% | +$623 | ﹤0.01% | 387 |
|
|
2024
Q4 | $2.07K | Hold |
15
| – | – | ﹤0.01% | 438 |
|
|
2024
Q3 | $2.24K | Hold |
15
| – | – | ﹤0.01% | 402 |
|
|
2024
Q2 | $2.05K | Hold |
15
| – | – | ﹤0.01% | 407 |
|
|
2024
Q1 | $2.27K | Hold |
15
| – | – | ﹤0.01% | 394 |
|
|
2023
Q4 | $1.89K | Hold |
15
| – | – | ﹤0.01% | 408 |
|
|
2023
Q3 | $1.4K | Hold |
15
| – | – | ﹤0.01% | 421 |
|
|
2023
Q2 | $1.34K | Hold |
15
| – | – | ﹤0.01% | 450 |
|
|
2023
Q1 | $1.61K | Hold |
15
| – | – | ﹤0.01% | 444 |
|
|
2022
Q4 | $1.81K | Hold |
15
| – | – | ﹤0.01% | 412 |
|
|
2022
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 457 |
|
|
2022
Q2 | $1K | Hold |
15
| – | – | ﹤0.01% | 462 |
|
|
2022
Q1 | $2K | Sell |
15
-3
| -17% | -$400 | ﹤0.01% | 437 |
|
|
2021
Q4 | $2K | Sell |
18
-1
| -5% | -$111 | ﹤0.01% | 476 |
|
|
2021
Q3 | $3K | Hold |
19
| – | – | ﹤0.01% | 442 |
|
|
2021
Q2 | $2K | Sell |
19
-2
| -10% | -$211 | ﹤0.01% | 502 |
|
|
2021
Q1 | $3K | Sell |
21
-3
| -13% | -$429 | ﹤0.01% | 495 |
|
|
2020
Q4 | $4K | Buy |
24
+2
| +9% | +$333 | ﹤0.01% | 452 |
|
|
2020
Q3 | $3K | Hold |
22
| – | – | ﹤0.01% | 469 |
|
|
2020
Q2 | $3K | Hold |
22
| – | – | ﹤0.01% | 463 |
|
|
2020
Q1 | $3K | Buy |
22
+11
| +100% | +$1.5K | ﹤0.01% | 438 |
|
|
2019
Q4 | $2K | Buy |
+11
| New | +$2K | ﹤0.01% | 420 |
|